from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0648/-

LFCtreatmentdescriptionclass of inhibitor

-0.306

Amikacinug/mL Amikacintranslation

0.436

Cap5-10ug/mL Capreomycintranslation

1.214

Rox10-50 ug/mL Roxithromycintranslation

-0.377

SM2-5 ug/mL Streptomycintranslation

0.159

Tet5-10 ug/mL Tetracyclinetranslation

0.493

Rif0.2-5ug/mL Rifampicintranscription

0.520

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.449

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.809

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.221

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.059

Clofazimine10-13 ug/mL Clofaziminerespiration

0.016

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.208

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.345

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.137

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.172

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.372

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.336

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.285

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

2.043

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.234

KCN5-20 ug/mL Potassium cyaniderespiration

-0.247

NaN30.2-2 mM Sodium aziderespiration

0.943

Nigericin50 uM Nigericinrespiration

-0.441

TRC10-150 ug/mL Triclosanrespiration

-1.035

TRZ10-25 ug/mL Thioridazinerespiration

0.600

Valinomycin0.5-10 uM Valinomycinrespiration

-0.250

ZnSO42 mM ZnSO4respiration

3.177

menadione6-10 ug/mL Menadionerespiration

-0.256

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.838

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.698

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.166

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.606

NRP_1Non-replicating persistence stage 1dosRassociated

-0.224

Amp0.2mg/mL AmpicillincellWall

-0.651

Cephalexin20-100 ug/mL CephalexincellWall

-0.500

Cerulenin0.32-5 ug/mL CerulenincellWall

0.239

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.142

EMB10-20 ug/mL EthambutolcellWall

-0.702

Eta12-40 ug/mL EthionamidecellWall

-0.743

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.257

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.412

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.089

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.843

BZA0.12 mg/mL BenzamidearomaticAmides

0.687

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.004

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.169

H2O24 mM hydrogen peroxideDNAdamaging

-0.131

Levo10 ug/mL LevofloxacinDNAdamaging

-0.282

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.688

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.345

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.633

UVUV-irradiationDNAdamaging

1.756

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.195

Antimycin12.5-50 ug/mL Antimycin A?

-0.241

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.870

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.910

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.116

PA8240.2-2 ug/mL PA-824?

-0.364

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.754

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.169

Verapamil50 uM Verapamil?

-0.027

mercaptoethanol2 mM 2-Mercaptoethanol?

0.625

methoxatin10-20 ug/mL Methoxatin?